Drug specialist doubles value

Article Abstract:

A team of chemists from Oxford University looks set to pocket millions of pounds from spin-off company VASTox plc, which has doubled its value to UKPd58 million in less than one year. The company, which develops drugs to treat rare diseases, was started two years ago by six scientists from the chemistry department at Oxford who invested UKPd100,000 in the company. The company was floated in October 2004 and valued at UKPd30 million.

Research and Development in the Physical, Engineering, and Life Sciences, Securities issued, listed, Chemists, Company investment, Investments, Securities, Investors, Company securities, Pharmaceutical research, Spinoff company, Spinoffs (Corporate)

---

Transfers prove costly

Article Abstract:

Many university technology-transfer offices fail to cover their costs, according to an investigation by The Times Higher. At least ten offices responsible for exploiting the ideas of academics are spending over GBP 1 million more than they generate while a similar number make money or break even.

Reports

---

OU nets access funding windfall

Article Abstract:

The Higher Education Funding Council for England has announced that GBP 344 million will be allocated to help English universities to recruit students from poor backgrounds. The Open University will receive GBP 29 million in 2006, almost four times as much as any other university.

Open University, Higher Education Funding Council for England

Similar abstracts:

• Abstracts: AUT demands stall pay deal. AUT and employers square up over pay
• Abstracts: Official reports 'dish the dirt'. Referees deliver online scolding. Watchdog warning over state intrusion
• Abstracts: Valid students denied UK entry. The postgrad cashpot. Backlash may put boycott in jeopardy
• Abstracts: Report slams imprudent leadership at Maori college. NZ reforms to ends cash-cow courses. NZ universities seek distinction
• Abstracts: Degree plan splits Welsh. Election debate plays out to few faithful. Liverpool set for final China deal

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.